Education & Advocacy Preserving Multiple Pathways to Recovery | CSDAP2022-03-25T17:09:30-04:00
CSDAP | Education and Advocacy Preserving Multiple Pathways to Recovery
SUBSCRIBE
DONATE NOW
DONATE NOW
Policy Makers
Practitioners
Communities

The Addiction Crisis and Our Mission

Find Out More

Current Posts

White House 2022 drug strategy includes recovery support services

June 2nd, 2022|

President Joe Biden sent his Administration’s inaugural National Drug Control Strategy to Congress at a time when drug overdoses have reached a record high. The Strategy delivers on the call to action in President Biden’s Unity Agenda through a whole-of-government approach to beat the overdose epidemic. It proposes targeted actions to expand access to evidence-based prevention, harm reduction, treatment and recovery services while reducing the supply of drugs like fentanyl.

Scientists Say Your “Mind” Isn’t Confined to Your Brain, or Even Your Body

May 27th, 2022|

What is a mind? Defining the concept is a surprisingly slippery task. The mind is the seat of consciousness, the essence of your being. Without a mind, you cannot be considered meaningfully alive. So what exactly, and where precisely, is it? This new understanding has potentially broad implications for the field of addiction and treatment.

Making the Case for Multiple Pathways to Recovery

May 25th, 2022|

The typical coverage of addiction treatment and recovery tends to obscure the fact that many people recover from addiction. While the pain and anguish experienced by the families and friends of those who do not recover is undeniable, it is likewise undeniable that many do recover. To the casual observer, who only follows popular depictions, this might not be apparent.

SAMHSA Treatment Website Contains Inaccurate Information, Experts Say

May 20th, 2022|

The national government website designed to help people find addiction treatment contains inaccurate and outdated information, addiction experts tell Kaiser Health News. The site, Findtreatment.gov, has information about more than 13,000 state-licensed treatment facilities, including what types of services are provided, which insurance plans the facilities accept and what ages they serve.

Congress weighs in on pharma industry conflicts of interest

May 18th, 2022|

Global consulting leader McKinsey & Company drew unwanted attention in 2020 when a bankruptcy proceeding revealed that it guided the marketing strategy for disgraced opioid seller Purdue Pharma. Now McKinsey is under scrutiny from Congress after revelations that at least 22 employees who were consulting for Purdue and other opioid producers were also doing work for government agencies tasked with regulating opioid use.

Doctors, companies push to keep looser rules for prescribing opioid treatment drugs

May 13th, 2022|

WASHINGTON — It got a lot easier for patients with opioid addiction to get their medication remotely during the pandemic — and now addiction doctors and telehealth companies are pushing Congress to make those flexibilities permanent. Before Covid-19, patients had to see a doctor in person for prescriptions to help them with their addictions, like buprenorphine. Now, at least temporarily, they can get them via telehealth appointments. Experts say loosening the rules helped eliminate longstanding barriers to addiction care, like a lack of transportation or a shortage of clinicians who prescribe medically assisted treatment, especially in rural communities. But the changes are temporary, tied to the state of “emergency” associated with the pandemic — and proponents want them made permanent.

Study: Natural Recovery from Alcohol and Drug Problems

May 10th, 2022|

The study is titled: Natural recovery from alcohol and drug problems: methodological review of the research with suggestions for future directions and published in PubMed.gov. Aims: The methodology of studies that reported data on individuals who recovered from an alcohol or other drug problem (cigarette smokers were excluded) without formal help or treatment were reviewed. Conclusions: Based on this review, future natural recovery studies should: (a) report respondents' demographic characteristics at the time of their recovery; (b) describe respondents' pre-recovery problem severity; (c) explore in some depth what factors, events or processes are associated with the self-change process; (d) provide corroboration of respondents' self-reports; (e) examine factors related to the maintenance of recoveries; (f) conduct interviews with individuals who have naturally recovered from cocaine, marijuana and polydrug abuse; (g) include a second interview at a later time to examine stability of natural recoveries; and (h) require a minimum 5-year recovery time frame.

The movement to expand methadone access to treat opioid addiction

May 6th, 2022|

Now officials at the Substance Abuse and Mental Health Services Administration are considering permanent changes to federal methadone rules. A National Academy of Medicine workshop on methadone regulations on March 3 and 4 may signal an inflection point.

Any changes to federal rules, however, could face significant resistance from methadone clinics — many of them for-profit — whose financial models are built on daily patient encounters, counseling, and regular drug tests. “There are some entities who have a financial interest in keeping things the way that they are,” Ryan said. “Change costs money.”

Go to Top